Selegiline: a reappraisal of its role in Parkinson disease.

Selegiline: a reappraisal of its role in Parkinson disease.

Item
http://www.wikidata.org/entity/Q38010624
Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson's disease.Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's disease.Rational drug discovery design approaches for treating Parkinson's disease.Cinnamamide Derivatives for Central and Peripheral Nervous System Disorders--A Review of Structure-Activity Relationships.A critical appraisal of the selegiline transdermal system for major depressive disorder.Analysis and prediction of drug-drug interaction by minimum redundancy maximum relevance and incremental feature selection.Effects of eldepryl on glial cell proliferation and activation in the substantia nigra and striatum in a rat model of Parkinson's disease.
P2860

Selegiline: a reappraisal of its role in Parkinson disease.

Item
http://www.wikidata.org/entity/Q38010624
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Selegiline: a reappraisal of its role in Parkinson disease.
@en
type
label
Selegiline: a reappraisal of its role in Parkinson disease.
@en
prefLabel
Selegiline: a reappraisal of its role in Parkinson disease.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Selegiline: a reappraisal of its role in Parkinson disease.
@en
P2093
P304
P31
P356
10.1097/WNF.0B013E318255838B
P433
P478
P50
P577
P698
P921